Citations

Clear

334 citation(s) found for "Jacobs, C".

Airway-Occluding Mucus Plugs and Mortality in Patients With Chronic Obstructive Pulmonary Disease
Díaz, Alejandro A. , Orejas, J. , Grumley, Scott , Nath, Hrudaya , Wang, Wei , Yen, Andrew , Kligerman, Seth , Jacobs, Kathleen, Manapragada, Padma P. , Abozeed, Mostafa , Zahid, Mohd , Ahmed, Asmaa , Terry, Nina , Sonavane, Sushilkumar K. , Washko, George R. , Estépar, Raúl San Jośe , San Jose Estepar, Raul , Diaz, Alejandro A , Dolliver, Wojciech Remington , Yen, Andrew, Aziz, Muhammad Usman , Estépar, R. San José , Kim, Victor, Make, Barry J. , Han, MeiLan King , Cho, Michael H.

Mayo Clinic

JAMA | May 21, 2023 | Volume: 329 | Issue: 21 | Pages: 1832

10.1001/jama.2023.2065 | PMID 37210745 Get It

Importance Airway mucus plugs are common in patients with chronic obstructive pulmonary disease (COPD); however, the association of airway mucus plugging and mortality in patients with COPD is unknown. Objective To determine whether airway mucus plugs identified on chest computed tomography (CT) were associated with increased all-cause mortality. Design, Setting, and Participants Observational retrospective analysis of prospectively collected data of patients with a diagnosis of COPD in the Genetic Epidemiology of COPD cohort. Participants were non-Hispanic Black or White individuals, aged 45 to 80 years, who smoked at least 10 pack-years. Participants were enrolled at 21 centers across the US between November 2007 and April 2011 and were followed up through August 31, 2022. Exposures Mucus plugs that completely occluded airways on chest CT scans, identified in medium- to large-sized airways (ie, approximately 2- to 10-mm lumen diameter) and categorized as affecting 0, 1 to 2, or 3 or more lung segments. Main Outcomes and Measures The primary outcome was all-cause mortality, assessed with proportional hazard regression analysis. Models were adjusted for age, sex, race and ethnicity, body mass index, pack-years smoked, current smoking status, forced expiratory volume in the first second of expiration, and CT measures of emphysema and airway disease. Results Among the 4483 participants with COPD, 4363 were included in the primary analysis (median age, 63 years [IQR, 57-70 years]; 44% were women). A total of 2585 (59.3%), 953 (21.8%), and 825 (18.9%) participants had mucus plugs in 0, 1 to 2, and 3 or more lung segments, respectively. During a median 9.5-year follow-up, 1769 participants (40.6%) died. The mortality rates were 34.0% (95% CI, 32.2%-35.8%), 46.7% (95% CI, 43.5%-49.9%), and 54.1% (95% CI, 50.7%-57.4%) in participants who had mucus plugs in 0, 1 to 2, and 3 or more lung segments, respectively. The presence of mucus plugs in 1 to 2 vs 0 and 3 or more vs 0 lung segments was associated with an adjusted hazard ratio of death of 1.15 (95% CI, 1.02-1.29) and 1.24 (95% CI, 1.10-1.41), respectively. Conclusions and Relevance In participants with COPD, the presence of mucus plugs that obstructed medium- to large-sized airways was associated with higher all-cause mortality compared with patients without mucus plugging on chest CT scans.
Whole Genome Sequencing Analysis of Mucus Plugging in Chronic Obstructive Pulmonary Disease (COPD)
Medicine, Trans-Omics in Precision, Silverman, E.K., Nath, H.P., Orejas, J. , Yen, Andrew , Jacobs, Kathleen, Manapragada, Padma P. , Abozeed, Mostafa , Zahid, Mohd , Sonavane, Sushilkumar K. , Cho, M.H. , Kim, Katherine Callaway , Grumley, Scott , Dolliver, Wojciech Remington , Yen, A., Aziz, Muhammad Usman , Díaz, Alejandro A.

Mayo Clinic

A24. COPD PHENOTYPES: LOOKING OUTSIDE THE LUNG | May 1, 2023 | Volume: No volume available | Issue: No issue available | Pages: A1153-A1153

10.1164/ajrccm-conference.2023.207.1_meetingabstracts.a1153 Get It

Airway Mucus Plugs and Chronic Obstructive Pulmonary Disease Exacerbations
Kim, V., Nath, H.P., Yen, A., Wang, Wei , Orejas, J. , Kligerman, Seth , Jacobs, Kathleen, Espinosa, C. Cano, Estebar, R. San Jose, Manapragada, Padma P. , Abozeed, Mostafa , Terry, Nina , Zahid, Mohd , Sonavane, Sushil, Cho, M.H. , Grumley, Scott , Dolliver, Wojciech Remington , Aziz, Muhammad Usman , Estépar, Raúl San Jośe , Díaz, Alejandro A.

Mayo Clinic

B22. NEW TREATMENTS AND NOVEL TARGETS FOR COPD AND ALPHA-1 | May 1, 2023 | Volume: No volume available | Issue: No issue available | Pages: A2858-A2858

10.1164/ajrccm-conference.2023.207.1_meetingabstracts.a2858 Get It

Persistent Airway Mucus Plugs and Changes in Lung Function in COPD
Mettler, S.K., Nath, H.P., Orejas, J. , Yen, A.A., Kligerman, Seth , Jacobs, Kathleen, Manapragada, Padma P. , Abozeed, Mostafa , Zahid, Mohd , Ahmed, Asmaa , Terry, Nina , Elalami, Rim, Sonavane, Sushilkumar K. , Billatos, Ehab , Wang, Wei , Cho, M.H. , DIAZ, ALEJANDRO A, Grumley, Scott , Dolliver, Wojciech Remington , Aziz, Muhammad Usman , Estépar, Raúl San Jośe

Mayo Clinic

B22. NEW TREATMENTS AND NOVEL TARGETS FOR COPD AND ALPHA-1 | May 1, 2023 | Volume: No volume available | Issue: No issue available | Pages: A2857-A2857

10.1164/ajrccm-conference.2023.207.1_meetingabstracts.a2857 Get It

Silent Airway Mucus Plugs in COPD and Association With Disease Severity and Outcomes
Mettler, S.K., Nath, H.P., Orejas, J. , Yen, A., Kligerman, Seth , Jacobs, Kathleen, Manapragada, Padma P. , Abozeed, Mostafa , Zahid, Mohd , Ahmed, Asmaa , Terry, Nina , Elalami, Rim, Sonavane, Sushilkumar K. , Billatos, Ehab , Wang, Wei , Cho, M.H. , Grumley, Scott , Dolliver, Wojciech Remington , Aziz, Muhammad Usman , Estépar, R. San José , Estépar, Raúl San Jośe , Díaz, Alejandro A.

Mayo Clinic

D92. NOVEL IMAGING AND PHYSIOLOGIC MEASURES IN COPD | May 1, 2023 | Volume: No volume available | Issue: No issue available | Pages: A6542-A6542

10.1164/ajrccm-conference.2023.207.1_meetingabstracts.a6542 Get It

Mortality and Major Adverse Cardiac Events in Patients With Breast Cancer Receiving Radiotherapy: The First Decade
Jacobs, J. , L’Hoyes, Wouter , Lauwens, Lieselotte , Yu, Yu‐Ling , Brusselmans, Marius , Weltens, Caroline , Voigt, Jens‐Uwe , Wildiers, Hans , Neven, Patrick , Herrmann, Joerg , Janssens, Stefan , Aelst, Lucas Van , Jacobs, Johanna E J , Thijs, Lutgarde , Staessen, Jan A , Janssens, Stefan , Van Aelst, Lucas N L , Voigt, Jens-Uwe , Wildiers, Hans

Mayo Clinic

Journal of the American Heart Association | April 7, 2023 | Volume: 12 | Issue: 8 | Pages: No page available

10.1161/jaha.122.027855 | PMID 37026536 Get It

Background Treatment for breast cancer (BC) frequently involves radiotherapy. Guidelines recommend screening for cardiac adverse events starting 10 years after radiotherapy. The rationale for this interval is unclear. Methods and Results We aimed to study cardiovascular event rates in the first decade following curative radiotherapy for BC. We compared mortality and cardiovascular event rates with an age‐ and risk factor‐matched control population. We included 1095 patients with BC (mean age 56±12 years). Two hundred and eighteen (19.9%) women died. Cancer and cardiovascular mortality caused 107 (49.1%) and 22 (10.1%) deaths, respectively. A total of 904 cases were matched to female FLEMENGHO (Flemish Study on Environment, Genes and Health Outcomes) participants. Coronary artery disease incidence was similar (risk ratio [RR], 0.75 [95% CI, 0.48–1.18]), yet heart failure (RR, 1.97 [95% CI, 1.19–3.25]) and atrial fibrillation/flutter (RR, 1.82 [95% CI, 1.07–3.08]) occurred more often in patients with BC. Age (hazard ratio [HR], 1.033 [95% CI, 1.006–1.061], P =0.016), tumor grade (HR, 1.739 [95% CI, 1.166–2.591], P =0.007), and neoadjuvant treatment setting (HR, 2.782 [95% CI, 1.304–5.936], P =0.008) were risk factors for mortality. Risk factors for major adverse cardiac events were age (HR, 1.053 [95% CI, 1.013–1.093]; P =0.008), mean heart dose (HR, 1.093 [95% CI, 1.025–1.167]; P =0.007), history of cardiovascular disease (HR, 2.386 [95% CI, 1.096–6.197]; P =0.029) and Mayo Clinic Cardiotoxicity Risk Score (HR, 2.664 [95% CI, 1.625–4.367]; P <0.001). Conclusions Ten‐year mortality following curative treatment for unilateral BC was mainly cancer related, but heart failure and atrial fibrillation/flutter were already common in the first decade following irradiation. Mean heart dose, pre‐existing cardiovascular diseases, and Mayo Clinic Cardiotoxicity Risk Score were risk factors for cardiac adverse events. These results suggest a need for early dedicated cardio‐oncological follow‐up after radiotherapy.
Abstract P226: Aerobic and Muscle Strengthening Physical Activity and Television Viewing Are Independently Associated With Odds of Nonalcoholic Fatty Liver Disease: The Cardia Study
Mathew, Mahesh, VanWagner, Lisa B. , Carr, Jeffrey, Reis, Jared P. , VanWagner, Lisa B , McDonough, Daniel J. , Pope, Zachary , Schreiner, Pamela J. , Jacobs, David R. , Terry, James G. , Gabriel, Kelley Pettee

Mayo Clinic

Circulation | March 14, 2023 | Volume: 147 | Issue: Suppl_1 | Pages: No page available

10.1161/circ.147.suppl_1.p226 Get It

Introduction: The prevalence of nonalcoholic fatty liver disease (NAFLD) in US adults is over 25%, yet the etiology of lifestyle factors in the development of NAFLD remains understudied. We examined the independent and joint associations among aerobic physical activity (PA) intensity (moderate, vigorous) and PA type (aerobic, muscle strengthening), television viewing (TV), and odds of NAFLD. Hypothesis: Higher levels of aerobic and muscle strengthening PA are associated with lower odds of NAFLD, and higher levels of TV are associated with higher odds of NAFLD. Methods: We analyzed data from Year 25 of the CARDIA cohort study. Our exposures (moderate and vigorous aerobic and muscle strengthening PA, TV; hr/wk) were assessed using validated questionnaires. Our outcome (NAFLD) was measured using non-contrast computed tomography. We constructed multivariable logistic regression models to examine the independent and joint associations between PA (moderate or vigorous aerobic and strength), TV, and odds of NAFLD. Covariates were sex, age, race, study center, education, diet, smoking status, alcohol consumption, and waist circumference. Results: 2726 participants (648 with NAFLD) were analyzed (mean (SD) age, 50.1 (3.6) years; 49% Black; 43% male). Fully adjusted odds ratios per IQR-standardized continuous PA and TV were: moderate aerobic PA (IQR = 4.3), 0.93 (95% CI, 0.81-1.07); vigorous aerobic PA (IQR = 1.9), 0.63 (95% CI, 0.55-0.73); muscle strengthening PA (IQR = 3.3), 0.80 (95% CI, 0.07-0.92); and TV (IQR = 14.0), 1.20 (95% CI, 1.10-1.32). Only vigorous aerobic PA remained statistically significant after waist circumference adjustment, 0.83 (95% CI, 0.70-0.98). A PA-TV index model (Figure) indicated the combination of higher vigorous aerobic and muscle strengthening PA and lower TV resulted in an odds ratio of 0.23 (95% CI, 0.15-0.37). Conclusion: Concurrent higher levels of vigorous aerobic PA (≥2 hr/wk), muscle strengthening PA (≥2 hr/wk), and lower levels of TV (<7 hr/wk) were associated with 77% lower odds of NAFLD.
Commentary: Gender differences in payments to cardiothoracic surgeons are unacceptable
Jacobs, Jeffrey P. , Nelson, Jennifer S. , Fuller, Stephanie , Karamlou, Tara , Molena, Daniela , Preventza, Ourania , Romano, Jennifer C., Jacobs, Jeffery P , Antonoff, Mara B. , Blackmon, Shanda

Mayo Clinic

European Journal of Cardio-Thoracic Surgery | March 13, 2023 | Volume: 63 | Issue: 3 | Pages: No page available

10.1093/ejcts/ezad080 | PMID 36912682 Get It

Every effort must be made by the leaders in our field, as well as by every individual cardiothoracic surgeon, to assure equal opportunity for all cardiothoracic surgeons, regardless of race, gender or any other sociodemographic source of bias. Every effort must be made by every surgeon, not just those in particular leadership roles. Opportunities for advancement must be equal in multiple domains, including clinical practice, patient referral, clinical leadership, academic leadership, institutional leadership and leadership in professional medical and surgical societies. Such actions to minimize bias and promote inclusivity will also ensure that cardiothoracic surgical care is provided by a workforce that represents the diversity of patients whom we serve. In the final analysis, it is an absolute fact that gender differences in payments to cardiothoracic surgeons are absolutely unacceptable and cannot be tolerated.